U.S.Army Clinical Trial with Hantavirus DNA Gene Therapy Injection-98% of Participants Suffered Adverse Events

According to Nicolas Hulscher (Epidemeologist and Foundation Administrator at the McCullough Foundation) via LinkedIn…’The US Army already ran a clinical trial with an Andes strain hantavirus DNA gene-therapy injection — the exact same strain behind the cruise ship outbreak.

98% of participants suffered adverse events.

The DNA plasmid was created at the Fort Detrick BSL-4 army lab.’….

Safety and Immunogenicity of an Andes Virus DNA Vaccine by Needle-Free Injection: A Randomized, Controlled Phase 1 Study

Stan Szymanski (or Encouraging Angels) is not a medical doctor. This is not medical advice. In all matters pertaining to the health and care of a human being consult a medical doctor. This is not legal, financial or personal advice. Consult appropriate professionals in those fields for that type of advice. For informational purposes only.